Stock & Company Details
AN2 Therapeutics Inc $ANTX
Price:
N/A
N/A
38M
$171M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.25
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
ANTX technical indicators
Latest AN2 Therapeutics Inc (ANTX) indicator readings as of 2026-10-29.
ANTX's 14-day RSI is 57.5, in neutral territory. At $4.69 it is trading 15.7% above its 200-day moving average of $4.05, and below its 50-day average of $4.92. Price sits in the middle of its Bollinger Bands ($2.71 to $5.61). ADX reads 29.3, indicating a trending market.
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
Finance Bot
Ask your questions
Start by typing a question below.
